FDA OKs ADHD Drug Vyvanse for Adults

摘要：April 23, 2008 -- The FDA has approved the drug Vyvanse for the treatment ofattention deficit hyperactivity disorder (ADHD) in adults, according to thedrug company Shire, which makes Vyvanse。 Vyvanse, a stimulant drug,?was firstapproved by the FDA in 2007 to treat ADHD symptoms in children ag......

• 临床快报
• 药市动态
• 违法广告
• 医保动态
• 药品价格
• 流感疫情
• 保健常识
• 妇科课堂
• 医改动态

April 23, 2008 -- The FDA has approved the drug Vyvanse for the treatment of attention deficit hyperactivity disorder (ADHD) in adults, according to the drug company Shire, which makes Vyvanse.

Vyvanse, a stimulant drug,?was first approved by the FDA in 2007 to treat ADHD symptoms in children ages 6-12.

Shire says the FDA approved Vyvanse for adult use based on a clinical trial of 414 adults ages 18-55 who took Vyvanse or a placebo pill for four weeks. Patients taking Vyvanse "experienced significant improvements in ADHD symptom control within one week of treatment with once-daily Vyvanse," says Shire.

All three doses of Vyvanse that were studied -- 30 milligrams, 50 milligrams, and 70 milligrams -- trumped the placebo; the most commonly reported adverse events were decreased appetite, difficulty in?falling asleep, and dry mouth, notes Shire.

?

发布日期：2008-4-25

• 相关主题关键字：
• FDA
• OKs
• ADHD
• Drug

输入您的搜索字词 提交搜索表单 资料 产品